Systemic sclerosis: a prototypic multisystem fibrotic disorder
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
A unique feature of systemic sclerosis (SSc) that distinguishes it from other fibrotic disorders is that autoimmunity and vasculopathy characteristically precede fibrosis. Moreover, fibrosis in SSc is not restricted to a single organ, but rather affects many organs and accounts for much of the morbidity and mortality associated with this disease. Although immunomodulatory drugs have been used extensively in the treatment of SSc, no therapy to date has been able to reverse or slow the progression of tissue fibrosis or substantially modify the natural progression of the disease. In this Review, we highlight recent studies that shed light on the cellular and molecular mechanisms underlying the fibrotic process in SSc and that identify cellular processes and intra- and extracellular proteins as potential novel targets for therapy in this prototypic multisystemic fibrotic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244
RetractedThe Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105408200 · Cited by 1,158
Diversity, topographic differentiation, and positional memory in human fibroblasts
Chang, H. Y., Chi, J.-T., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162488599 · Cited by 1,151
Cited by
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
“In the case of systemic sclerosis, vascular changes are a prominent and early manifestation of the disease, with impaired angiogenesis leading to the progressive disappearance of blood vessels [28,29].”
BackgroundCox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
Self-citationTh22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling
Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F., Odorisio, T., Traidl-Hoffmann, C., Behrendt, H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40202 · Cited by 1,052
Implications of macrophage polarization in autoimmunity
Funes, S. C., Rios, M., Escobar‐Vera, J., & Kalergis, A. M. (2018) · Immunology · doi:10.1111/imm.12910 · Cited by 1,005
The myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
The myofibroblast: Paradigm for a mechanically active cell
Hinz, B. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.09.020 · Cited by 698
Ghosh, A. K., & Vaughan, D. E. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22783 · Cited by 679
Koenig, M., Joyal, F., Fritzler, M. J., Roussin, A., Abrahamowicz, M., Boire, G., Goulet, J., Rich, É., Grodzicky, T., Raymond, Y., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24038 · Cited by 615
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.001 · Cited by 580
MicroRNA‐29, a key regulator of collagen expression in systemic sclerosis
Maurer, B., Stanczyk, J., Jüngel, A., Akhmetshina, A., Trenkmann, M., Brock, M., Kowal‐Bielecka, O., Gay, R. E., Michel, B. A., Distler, J. H. W., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27443 · Cited by 539
Interferon target-gene expression and epigenomic signatures in health and disease
Barrat, F. J., Crow, M. K., & Ivashkiv, L. B. (2019) · Nature Immunology · doi:10.1038/s41590-019-0466-2 · Cited by 530
Zeisberg, M., & Kalluri, R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2012 · Cited by 462
Review: Evidence That Systemic Sclerosis Is a Vascular Disease
Matucci‐Cerinic, M., Kahaleh, B., & Wigley, F. M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37988 · Cited by 452
Borges, F. T., Melo, S. A., Özdemir, B. C., Kato, N., Revuelta, I., Miller, C. A., Gattone, V. H., LeBleu, V. S., & Kalluri, R. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101031 · Cited by 419
Mesenchymal Cells of the Intestinal Lamina Propria
Powell, D. W., Pinchuk, I. V., Saada, J. I., Chen, X., & Mifflin, R. C. (2011) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100646 · Cited by 394
Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
Bhattacharyya, S., Wei, J., & Varga, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.149 · Cited by 381
“Immune perturbations and vascular injury precede and contribute to the development of fibrosis, which, in turn, further exacerbates vascular and immune damage”
Self-citationHinz, B. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0017-1 · Cited by 373
“In SSc, stiff fi brotic scars are the pathologic consequences of a series of events, including vascular dysfunction, autoimmune reactions, and infl ammation [ 3 ].”
BackgroundInfluentialTissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Chakraborty, D., Šumová, B., Mallano, T., Chen, C.-W., Distler, A., Bergmann, C., Ludolph, I., Horch, R. E., Gelse, K., Ramming, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01236-6 · Cited by 356
Rice, L. M., Padilla, C. M., McLaughlin, S. R., Mathes, A., Ziemek, J., Goummih, S., Nakerakanti, S., York, M., Farina, G., Whitfield, M. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77958 · Cited by 351
“In addition, skin fibrosis shares pathogenic features with fibrotic disease at other sites in patients with SSc, suggesting that agents successfully treating skin might show efficacy for other involved organs (11).”
BackgroundMorry, J., Ngamcherdtrakul, W., & Yantasee, W. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.011 · Cited by 333
Transforming growth factor β—at the centre of systemic sclerosis
Lafyatis, R. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.137 · Cited by 332
Tschumperlin, D. J., Ligresti, G., Hilscher, M. B., & Shah, V. H. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93561 · Cited by 330
The Pathogenesis of Systemic Sclerosis
Katsumoto, T. R., Whitfield, M. L., & Connolly, M. K. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130312 · Cited by 313
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis
Riemekasten, G., Philippe, A., Näther, M., Slowinski, T., Müller, D. N., Heidecke, H., Matucci-Cerinic, M., Czirják, L., Lukitsch, I., Becker, M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135772 · Cited by 302
Transforming growth factor β as a therapeutic target in systemic sclerosis
Varga, J., & Pasche, B. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.26 · Cited by 295
Self-citationInterstitial lung disease associated with systemic sclerosis (SSc-ILD)
Cottin, V., & Brown, K. K. (2019) · Respiratory Research · doi:10.1186/s12931-019-0980-7 · Cited by 292
Cellular interactions in the pathogenesis of interstitial lung diseases
Bagnato, G., & Harari, S. (2015) · European Respiratory Review · doi:10.1183/09059180.00003214 · Cited by 277
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Piera-Velazquez, S., Mendoza, F., & Jimenez, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040045 · Cited by 273
Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
Gressner, O. A., & Gressner, A. M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01826.x · Cited by 270
Platelet-derived serotonin links vascular disease and tissue fibrosis
Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101629 · Cited by 266
Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., et al. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14458 · Cited by 261
Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis
Lagares, D., Santos, A., Grasberger, P. E., Liu, F., Probst, C. K., Rahimi, R. A., Sakai, N., Kuehl, T., Ryan, J., Bhola, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3765 · Cited by 246
Fibronectin EDA Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor Signaling
Bhattacharyya, S., Tamaki, Z., Wang, W., Hinchcliff, M., Hoover, P., Getsios, S., White, E. S., & Varga, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008264 · Cited by 234
Self-citationWu, M., Melichian, D. S., Chang, E., Warner-Blankenship, M., Ghosh, A. K., & Varga, J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080574 · Cited by 233
“The pathogenesis of fibrosis remains incompletely understood.(2) Although inflammation is a prevalent early feature, its precise role in fibrosis remains controversial, and anti-inflammatory therapies are generally ineffective in reversing or slowing the progression of the process.”
BackgroundSelf-citationMechanical Aspects of Lung Fibrosis: A Spotlight on the Myofibroblast
Hinz, B. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201202-017aw · Cited by 228
Wei, J., Fang, F., Lam, A. P., Sargent, J. L., Hamburg, E., Hinchcliff, M. E., Gottardi, C. J., Atit, R., Whitfield, M. L., & Varga, J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34424 · Cited by 226
Self-citationWei, J., Melichian, D., Komura, K., Hinchcliff, M., Lam, A. P., Lafyatis, R., Gottardi, C. J., MacDougald, O. A., & Varga, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30312 · Cited by 214
Self-citationNox enzymes as novel targets for drug development
Lambeth, J. D., Krause, K.-H., & Clark, R. A. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0123-6 · Cited by 212
Dees, C., Schlottmann, I., Funke, R., Distler, A., Palumbo-Zerr, K., Zerr, P., Lin, N.-Y., Beyer, C., Distler, O., Schett, G., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203194 · Cited by 199
Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Lagares, D., Busnadiego, O., García‐Fernández, R. A., Kapoor, M., Liu, S., Carter, D. E., Abraham, D., Shi‐Wen, X., Carreira, P., Fontaine, B. A., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33482 · Cited by 192
Self-citationAkhmetshina, A., Dees, C., Pileckyte, M., Maurer, B., Axmann, R., Jüngel, A., Zwerina, J., Gay, S., Schett, G., Distler, O., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-105627 · Cited by 187
Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice
Zhang, Z., Shao, M., Hepler, C., Zi, Z., Zhao, S., An, Y. A., Zhu, Y., Ghaben, A. L., Wang, M.-Y., Li, N., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130239 · Cited by 187
“org also can undergo transdifferentiation, and morph into myofibroblasts with unique expression of α-smooth muscle actin (α-SMA) (36).”
BackgroundCastelino, F. V., & Varga, J. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3097 · Cited by 182
“When bound by active TGFβ, the cell surface TGFβ receptors transmit signals through phosphorylation of cytoplasmic Smad proteins, which translocate into the cell nucleus and trigger transcription of genes such as type I collagen, fi bro nectin, α-smooth muscle actin and connective tissue growth factor (CTGF), each of…”
BackgroundSelf-citationBorie, R., Crestani, B., Dieude, P., Nunes, H., Allanore, Y., Kannengiesser, C., Airo, P., Matucci-Cerinic, M., Wallaert, B., Israel-Biet, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070621 · Cited by 178
“Both IPF and SSc are considered as genetic complex diseases, and occur in genetically predisposed individuals who have experienced certain environmental or stochastic stimuli [3].”
BackgroundSelf-citationSpiera, R. F., Gordon, J. K., Mersten, J. N., Magro, C. M., Mehta, M., Wildman, H. F., Kloiber, S., Kirou, K. A., Lyman, S., & Crow, M. K. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143974 · Cited by 173
Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy
Wei, J., Bhattacharyya, S., Tourtellotte, W. G., & Varga, J. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.015 · Cited by 173
“Additional features that phenotypically define SSc fibroblasts include increased synthesis of extracellular matrix; constitutive production of cytokines and chemokines; altered expression of cell surface integrins and receptors for transforming growth factor-ß (TGF-ß), platelet-derived growth factor (PDGF) and the CC…”
BackgroundSelf-citationCollagen morphology and texture analysis: from statistics to classification
Mostaço-Guidolin, L. B., Ko, A. C.-T., Wang, F., Xiang, B., Hewko, M., Tian, G., Major, A., Shiomi, M., & Sowa, M. G. (2013) · Scientific Reports · doi:10.1038/srep02190 · Cited by 163
Integrins and integrin-related proteins in cardiac fibrosis
Chen, C., Li, R., Ross, R. S., & Manso, A. M. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.010 · Cited by 162
“Importantly, disorders that lead to fibrosis can share the complex interplay between inflammatory, epithelial, myofibroblast and ECM responses [5-7].”
BackgroundHedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Horn, A., Palumbo, K., Cordazzo, C., Dees, C., Akhmetshina, A., Tomcik, M., Zerr, P., Avouac, J., Gusinde, J., Zwerina, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34444 · Cited by 160
Pieroni, M., De Santis, M., Zizzo, G., Bosello, S., Smaldone, C., Campioni, M., De Luca, G., Laria, A., Meduri, A., Bellocci, F., et al. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.07.006 · Cited by 158
François, A., Chatelus, E., Wachsmann, D., Sibilia, J., Bahram, S., Alsaleh, G., & Gottenberg, J.-E. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4352 · Cited by 149
“They also synthesize collagen and are a major source of TGF-β 1 and TIMP-1 during the fibrotic process [28,29].”
Wu, M., Melichian, D. S., de la Garza, M., Gruner, K., Bhattacharyya, S., Barr, L., Nair, A., Shahrara, S., Sporn, P. H. S., Mustoe, T. A., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090241 · Cited by 125
Self-citationMendoza, F. A., Piera‐Velazquez, S., Farber, J. L., Feghali‐Bostwick, C., & Jiménez, S. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39421 · Cited by 121
Reich, N., Maurer, B., Akhmetshina, A., Venalis, P., Dees, C., Zerr, P., Palumbo, K., Zwerina, J., Nevskaya, T., Gay, S., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25056 · Cited by 112
“TGF and PDGF are overexpressed in SSc and are thought to be key players in the pathogenesis of SSc (26).”
BackgroundInhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
Krämer, M., Dees, C., Huang, J., Schlottmann, I., Palumbo-Zerr, K., Zerr, P., Gelse, K., Beyer, C., Distler, A., Marquez, V. E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201615 · Cited by 109
“INTRODUCTION Systemic sclerosis (SSc) is a connective tissue disease that primarily affects the skin, but also the lungs, heart and gastrointestinal tract.(1) The most obvious hallmark of SSc is the massive accumulation of extracellular matrix components in involved organs.”
BackgroundHaak, A. J., Tsou, P.-S., Amin, M. A., Ruth, J. H., Campbell, P., Fox, D. A., Khanna, D., Larsen, S. D., & Neubig, R. R. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.213520 · Cited by 103
T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease
Boin, F., De Fanis, U., Bartlett, S. J., Wigley, F. M., Rosen, A., & Casolaro, V. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23406 · Cited by 81
“Experimental data suggest that a network of potentially profibrotic cellular and humoral mediators is established within the target tissues in patients with SSc (18).”
BackgroundMartyanov, V., Kim, G.-H. J., Hayes, W., Du, S., Ganguly, B. J., Sy, O., Lee, S. K., Bogatkevich, G. S., Schieven, G. L., Schiopu, E., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187580 · Cited by 71
“Systemic sclerosis (SSc) is a clinically heterogeneous orphan disease characterized by autoimmunity, widespread microangiopathy and multi-organ fibrosis [1,2].”
BackgroundSelf-citationPonsoye, M., Frantz, C., Ruzehaji, N., Nicco, C., Elhai, M., Ruiz, B., Cauvet, A., Pezet, S., Brandely, M. L., Batteux, F., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208213 · Cited by 70
Papaioannou, I., Xu, S., Denton, C. P., Abraham, D. J., & Ponticos, M. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-06-0342 · Cited by 64
“In normal wound healing this is an essential process, allowing wound closure and reformation of lost connective tissue to support reepithelization (Leask and Abraham, 2004; Varga and Abraham, 2007).”
BackgroundInfluentialSelf-citationThe cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
Balistreri, E., Garcia-Gonzalez, E., Selvi, E., Akhmetshina, A., Palumbo, K., Lorenzini, S., Maggio, R., Lucattelli, M., Galeazzi, M., & Distler, J. W. H. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137539 · Cited by 56
“Systemic sclerosis (SSc) is a connective tissue disease of unknown aetiology that affects the skin and internal organs. In early stages, vascular injury and inflammation lead to the fibrosis of tissues, resulting in irreversible damage.”
BackgroundMartins, V., Gonzalez De Los Santos, F., Wu, Z., Capelozzi, V., Phan, S. H., & Liu, T. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.06.005 · Cited by 52
“SSc is a chronic systemic disease characterized by autoimmunity, vascular lesions, and progressive fibrosis of the lungs and skin.(16,17) The fibrotic component is dominant in SSc and is characterized by accumulation of collagens,(16) which results in a loss of tissue function.”
BackgroundLagares, D., Busnadiego, O., García-Fernández, R. A., Lamas, S., & Rodríguez-Pascual, F. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0446oc · Cited by 40
Jafarinejad‐Farsangi, S., Farazmand, A., Gharibdoost, F., Karimizadeh, E., Noorbakhsh, F., Faridani, H., Mahmoudi, M., & Jamshidi, A. R. (2016) · International Journal of Dermatology · doi:10.1111/ijd.13308 · Cited by 39
Samuel, G. H., Lenna, S., Bujor, A. M., Lafyatis, R., & Trojanowska, M. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.06.001 · Cited by 22
“SSc is an autoimmune connective tissue disease that is characterized by excess production and deposition of extracellular matrix proteins by activated fibroblasts (myofibroblasts) resulting in extensive fibrosis of skin and internal orgrans [8].”
BackgroundKarimizadeh, E., Gharibdoost, F., Motamed, N., Jafarinejad-Farsangi, S., Jamshidi, A., & Mahmoudi, M. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2408-0 · Cited by 20
Metadata
- Authors
- Varga, J., & Abraham, D.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 557-567
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2081741824
- Cited by
- 1,163
- References
- 114
- FWCI
- 43.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.